Sodium-glucose co-transporter-2 - Globe Thesis

Keyword [Sodium-glucose co-transporter-2] Result: 1 - 18 \| Page: 1 of 1
1.	Design, Synthesis And Antidiabetic Activities Of Novel Sodium-glucose Co-transporter 2(SGLT2) Inhibitors
2.	The Discovery Of Novel Anti-diabetic Candidate Targeting To Sodium-glucose Co-transporter 2
3.	Design,Synthesis And Biological Evaluation Of Novel Sodium Glucose Co-transporter 2(SGLT2)Inhibitors
4.	Efficacy And Safety Of Triple Therapy With Sodium Glucose Co-transporter 2(SGLT-2)Inhibitor Add-on To Dipeptidyl Peptidase-4(DPP-4)Inhibitor Plus Metformin For Type 2 Diabetes:A Systematic Review
5.	The Influence Of Acarbose/Dapagliflozin Monotherapy On Metabolism For Newly Diagnosed Type 2 Diabetes Mellitus
6.	Clinical Efficacy And Safety Of Dapagliflozin Combined With Insulin In The Treatment Of Type 2 Diabetes Mellitus
7.	Effect Of Dapagliflozin On Cardiovascular Risk Factors In Patients With Hypertension And Type 2 Diabetes
8.	Effects Of Dapagliflozin On Cardiovascular Outcomes In Patients With Unstable Angina Pectoris And Type 2 Diabetes After PCI
9.	Synthesis And Pharmacodynamics Study Of A Dual SGLT-1/SGLT-2 Inhibitor
10.	Meta-analysis Of The Long-term Safety Of Empagliflozin In The Treatment Of Type 2 Diabetes Melitus
11.	Effectiveness And Safety Of Sodium-glucose Co-transporter 2 Inhibitors In Treatment Of Diabetic Nephropathy:A Meta-analysis
12.	Effects Of Sodium-glucose Co-transporter 2 Inhibitor On Insulin Sensitivity And Serum GPC-4 In Patients With Type 2 Diabetes Mellitus
13.	The Effect Of Sodium-glucose Co-transporter 2 Inhibitiors On Albuminuria In Patients With Type 2 Diabetes: A Systematic Review
14.	Effects Of High Salt Diet On Glucose And Lipid Metabolism In Mice And Expression Of SGLT1 In Intestines And SGLT1/2 In Kidneys
15.	Efficacy And Prognosis Analysis Of Sodium-glucose Cotransporter-2 Inhibitor In The Treatment Of Heart Failure With Reduced Ejection Fraction
16.	Study On The Degree Of Protection And Short-Term Prognosis Of SGLT2I Against Myocardial Injury In STEMI Patients With T2DM
17.	Efficacy Of SGLT-2 Inhibitors In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: A Meta-Analysis
18.	Improvement Of Endocrine And Metabolism Abnormalities In Overweight And Obese Women With Polycystic Ovary Syndrome By Canagliflozin In Combination With Metformin
<<First <Prev Next> Last>> Jump to